Literature DB >> 10506047

Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden.

K Rödström1, C Bengtsson, L Lissner, C Björkelund.   

Abstract

OBJECTIVE: To assess whether risk factor profiles for cardiovascular disease differed, before starting treatment, between women who would subsequently use hormone replacement therapy and those who would remain untreated.
DESIGN: Prospective population study, initiated in 1968-9, with follow ups in 1974, 1980, and 1992.
SETTING: Gothenburg, Sweden. PARTICIPANTS: 1201 women born in 1918, 1922, and 1930, representative of women of the same age in the general population. MAIN OUTCOME MEASURES: Hormone replacement therapy as a function of initial systolic and diastolic blood pressure, waist and hip circumference, waist to hip ratio, body mass index, serum concentrations of cholesterol and triglycerides, smoking status, education, leisure time activity, and socioeconomic group.
RESULTS: 179 of the 1202 women (14.9%) used hormone replacement therapy sometime during the 24 year follow up period. Age adjusted models indicated that these women had significantly lower blood pressure, had less obesity, and belonged to a higher social group before the start of treatment than women who would remain untreated [corrected].
CONCLUSION: Women who would subsequently use hormone replacement therapy were already at lower cardiovascular risk before the start of treatment than women who would remain untreated. Some of the claimed beneficial effects of treatment may thus be explained by women who would use hormone replacement therapy representing a healthier cohort than women who would remain untreated.

Entities:  

Mesh:

Year:  1999        PMID: 10506047      PMCID: PMC28245          DOI: 10.1136/bmj.319.7214.890

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  20 in total

Review 1.  Estrogen and coronary heart disease in women.

Authors:  E Barrett-Connor; T L Bush
Journal:  JAMA       Date:  1991-04-10       Impact factor: 56.272

Review 2.  Consensus development conference: prophylaxis and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

3.  Ischaemic heart disease in women. A study based on a randomized population sample of women and women with myocardial infarction in Göteborg, Sweden.

Authors:  C Bengtsson
Journal:  Acta Med Scand Suppl       Date:  1973

4.  The study of women in Gothenburg 1968-1969--a population study. General design, purpose and sampling results.

Authors:  C Bengtsson; G Blohmé; L Hallberg; T Hällström; B Isaksson; K Korsan-Bengtsen; G Rybo; E Tibblin; G Tibblin; H Westerberg
Journal:  Acta Med Scand       Date:  1973-04

5.  The population study of women in Göteborg 1974--1975--the second phase of a longitudinal study. General design, purpose and sampling results.

Authors:  C Bengtsson; L Hallberg; T Hällström; A Hultborn; B Isaksson; J Lennartsson; O Lindquist; S Lindstedt; H Noppa; L Redvall; S Samuelsson
Journal:  Scand J Soc Med       Date:  1978

6.  Number of teeth and proximal periodontal bone height in relation to social factors.

Authors:  A Halling; C Bengtsson
Journal:  Swed Dent J       Date:  1984

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  Menopause and coronary heart disease. The Framingham Study.

Authors:  T Gordon; W B Kannel; M C Hjortland; P M McNamara
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

9.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

10.  The population study of women in Gothenburg 1980-81--the third phase of a longitudinal study. Comparison between participants and non-participants.

Authors:  C Bengtsson; T Gredmark; L Hallberg; T Hällström; B Isaksson; L Lapidus; O Lindquist; S Lindstedt; M Lurie; E Nyström
Journal:  Scand J Soc Med       Date:  1989
View more
  8 in total

1.  Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy.

Authors:  M M Mamdani; K Tu; C van Walraven; P C Austin; C D Naylor
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

Review 2.  Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.

Authors:  Susan E Bromley; Corinne S de Vries; Dawn Thomas; Richard D T Farmer
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study.

Authors:  E Løkkegaard; A T Pedersen; B L Heitmann; Z Jovanovic; N Keiding; Y A Hundrup; E B Obel; B Ottesen
Journal:  BMJ       Date:  2003-02-22

Review 4.  Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies.

Authors:  Jane Morley Kotchen; Theodore A Kotchen
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

5.  Perceived nervousness and moodiness associated with increased CVD but not cancer morbidity in pre- and postmenopausal women. Observations from the Population Study of Women in Gothenburg, Sweden.

Authors:  Dominique Hange; Lauren Lissner; Calle Bengtsson; Valter Sundh; Cecilia Björkelund
Journal:  Int J Gen Med       Date:  2009-07-30

6.  Performance of clinical referral criteria for bone densitometry in patients under 65 years of age assessed by spine bone mineral density.

Authors:  K Kayan; D de Takats; R Ashford; J A Kanis; E V McCloskey
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

7.  A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.

Authors:  Julia Hippisley-Cox; Mike Pringle; Nicola Crown; Carol Coupland
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

8.  The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study.

Authors:  Mihir M Sanghvi; Nay Aung; Jackie A Cooper; José Miguel Paiva; Aaron M Lee; Filip Zemrak; Kenneth Fung; Ross J Thomson; Elena Lukaschuk; Valentina Carapella; Young Jin Kim; Nicholas C Harvey; Stefan K Piechnik; Stefan Neubauer; Steffen E Petersen
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.